Mark Cuban jumps out of the Shark Tank and into generic pharma with a plan to offer dirt-cheap drugs
The call for a wholesale rewrite of drug pricing has taken on a fever pitch in recent years, regularly becoming part of presidential stump speeches and congressional horse trading. The focus is usually on high-price branded meds, but now a new shark is in the water going after pricey generics as well.
In an effort to offer low-cost alternatives to pricey generic medicines, billionaire investor Mark Cuban has put his name to a new company dubbed Mark Cuban Cost Plus Drugs — an on-the-nose moniker for sure, but one with the serious ambition of undercutting the market on targeted meds.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.